Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy »

Stanford Health Care

Prognostic usefulness of White Blood Cell count and temperature in acute myocardial infarction (from the CARDINAL Trial) AMERICAN JOURNAL OF CARDIOLOGY Patel, M. R., Mahaffey, K. W., Armstrong, P. W., Weaver, W. D., Tasissa, G., Hochman, J. S., Todaro, T. G., Malloy, K. J., Rollins, S., Theroux, P., Ruzyllo, W., Nicolau, J. C., Granger, C. B. 2005; 95 (5): 614-618

Abstract

White blood cell (WBC) count and temperature are 2 global measures of inflammation that are systematically gathered and easily identifiable in a clinical setting, unlike many other markers of inflammation being investigated in patients with coronary artery disease. The prognostic usefulness of the WBC count and temperature were evaluated in a large acute myocardial infarction trial, the Complement And ReDuction of INfarct size after Angioplasty or Lytics program. Baseline and serial measurements of WBC counts and temperature were correlated with infarct size and clinical outcome.

View details for Web of Science ID 000227156400013

View details for PubMedID 15721102